Lotus Bio-Technology Development Corp. Significantly Increases the Size of its Infrastructure and Farming Operation

HONG KONG, CHINA / ACCESSWIRE / August 17, 2017 / Lotus Bio-Technology Development Corp. (OTC PINK: LBTD), (the “Company”) is pleased to announce that it has significantly increased the size of its infrastructure and farming operation.

The local Hunan government and the company have entered into an Organic Land development agreement that will enable the company to develop the necessary infrastructure in the area. A newly acquired large section of land has been prepared for organic farming by the company while construction of roads, new watering systems, piping and utility networks has commenced. The total area of the new development is over 72,000,000 square feet. Upon completion this will result in approximately a 67% increase in land owned by the company. This increase in owned land will aid in continued expansion of projects, increased capital and help with future developments.

“We are obviously pleased with this unprecedented growth that the company is experiencing as we look to increase sales of our products,” stated William Ko President of Lotus.

About Lotus Bio-Technology Development Corp. Lotus Bio-Technology is a Hong Kong based bio-technology development company that specializes in the refining of organic materials and the production of natural consumer related products. The Company has the rights to farmland in China of 1,000 hectares which is approximately 100 football fields combined. Our mandate is to grow various plants under strict organic standards and produce organic based consumer related products which completely natural. The products will strike a balance between affordability and produced from an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones or other dangerous chemicals while ensuring a solid financial return for our shareholders. The Company is a publicly traded company having its common shares quoted on the OTC Markets under the symbol LBTD.

Cautionary Note Regarding Forward-Looking Statements: This news release contains forward-looking statements about our business or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as “believes,” “expects,” “intends,” “plans,” “anticipates,” “estimates” and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.

SOURCE: Lotus Bio-Technology Development Corp.

ReleaseID: 472856